Acute lymphoblastic leukaemia trials in France

In France 39 Also abroad 564

39 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 3Not yet taking people in France
PREV-CART - “A multicentric phase III randomized clinical trial open-label, comparing immunoglobulin replacement therapy (IgRT) and antibiotic prophylaxis (AP) in patients treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B cell acute lymphoblastic leukemia or a B cell lymphoma”
Where
Angers, Brest, Caen, Clermont-Ferrand, Grenoble Cedex 9, Lille Cedex, Limoges Cedex 1, Nantes, Nice, Paris, Pessac, Saint-Priest-en-Jarez, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy
People
228
Run by
Assistance Publique Hopitaux De Paris
See details and how to join2025-521571-30-00 · EU 2025-521571-30-00
Phase 1/2Taking people
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Where
Angers, Bobigny, Le Mans, Lille, Limoges, Lyon, Marseille, Nantes, Nice, Paris, Talence, Villejuif
Age
12 years and over
People
606 worldwide
Run by
Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555
Phase 2Taking people
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Where
Besancon Cedex, Bordeaux, Caen Cedex 9, Grenoble Cedex 9, Lille Cedex, Marseille, Nantes, Nice, Paris, Poitiers, Reims Cedex, Rennes, Rouen Cedex, Strasbourg Cedex 2, Toulouse Cedex 9
Age
Up to 17 years
People
250 worldwide
Run by
Charite University, Berlin, Germany
See details and how to joinNCT03590171 · EU 2024-513070-21-00
No phaseTaking people
Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring
Where
Metz
Age
1 year to 18 years
People
50
Run by
Centre Hospitalier Régional Metz-Thionville
See details and how to joinNCT06867289
Phase 2/3Taking people
A 3-cohort Randomized Study Evaluating the Role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults With Acute Lymphoblastic Leukemia
Where
Paris
Age
18 years to 65 years
People
1,200
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06860269
No phaseTaking people
Childhood B-acute Lymphoblastic Leukaemia and Role of CD9 Gene Regulation in Relapse
Where
Angers, Brest, Rennes
Age
0 years to 17 years
People
50
Run by
Rennes University Hospital
See details and how to joinNCT06649253
No phaseTaking people
Study of the Medullary Microenvironment in Acute Childhood Leukemia
Where
Tours
Age
1 year to 15 years
People
40
Run by
University Hospital, Tours
See details and how to joinNCT05792007
Phase 1/2Taking people
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
Where
Bordeaux, Lille Cedex, Lyon, Marseille, Nantes, Paris
Age
1 year to 21 years
People
26 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05658640 · EU 2022-501869-41-00
Phase 1/2Taking people
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Where
Bordeaux, Lille Cedex, Lyon, Marseille, Nantes, Paris
Age
1 year to 21 years
People
26 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05745714 · EU 2022-501867-42-01
Phase 1/2Taking people
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Where
Bordeaux, Lille Cedex, Lyon, Marseille, Nantes, Paris
Age
1 year to 21 years
People
26 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05751044 · EU 2022-501866-22-00
No phaseTaking people
Early Assessment of Cardiac Function After Treatment With CAR-T Cells
Where
Paris
Age
18 years and over
People
60
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06350994
Phase 2Taking people
GRAALL2014
Where
Amiens, Angers, Argenteuil Cedex, Avignon, Bayonne, Besançon, Bobigny, Brest, Caen, Clermont-Ferrand, Colmar Cedex, Corbeil Essonnes Cedex, Creteil Cedex, Dijon, Grenoble Cedex 9, Le Chesnay Rocquencourt, Lens, Lille Cedex, Limoges, Lyon, Marseille, Montpellier Cedex 5, Mulhouse, Nantes, Nice, Nice Cedex 2, Nimes Cedex 9, Orleans Cedex 2, Paris, Perpignan Cedex, Pessac Cedex, Pierre-Bénite, Poitiers, Pringy Cedex, Reims Cedex, Rennes, Roubaix, Rouen, Saint-Cloud, Strasbourg Cedex 2, Toulouse Cedex 9, Tours, Valenciennes, Vandoeuvre Les Nancy Cedex, Villejuif
Age
18 years and over
People
1,506 worldwide
Run by
Assistance Publique Hopitaux De Paris
See details and how to joinNCT02617004 · EU 2024-516103-16-00
Phase 1/2Taking people
Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence
Where
Bordeaux, Bron, Lille Cedex, Lyon, Marseille, Montpellier Cedex 5, Nantes, Paris, Pierre-Bénite, Rouen Cedex, Strasbourg Cedex 2, Vandoeuvre Les Nancy Cedex
Age
1 year to 25 years
People
26
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05310591 · EU 2024-514345-11-00
No phaseTaking people
The Patient Cohort of the National Center for Precision Medicine in Leukemia
Where
Bobigny, Paris
People
3,000
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05326919